Relationship between tumor biomarkers and efficacy in TH3RESA, a phase III study of trastuzumab emtansine (T-DM1) vs. treatment of physician's choice in previously treated HER2-positive advanced breast cancer
- Kim, S.-B.
- Wildiers, H.
- Krop, I.E.
- Smitt, M.
- Yu, R.
- Lysbet de Haas, S.
- Gonzalez-Martin, A.
ISSN: 1097-0215, 0020-7136
Datum der Publikation: 2016
Ausgabe: 139
Nummer: 10
Seiten: 2336-2342
Art: Artikel
